6 Significant barriers at national borders, including unnecessary procedures on the release and clearance of medical technolo- gies, prevent medical technology products from reaching the people who need them. Overly complex trade processes and documentation not only cause life-threatening delays but also raise costs, especially for the small and medium-sized busi- nesses and entrepreneurs who own and operate the majority of medical technology companies. More transparent and predictable border procedures make it easier for small and medium-sized businesses and entrepre- neurs to connect with customers for the first time. And countries where medical technology goods can be imported or exported within quick and reliable timeframes are attractive for new or expanded investments. AdvaMed is committed to working with its partners to enhance the movement of medical technologies across borders. This includes fast and efficient customs and port procedures. Therefore, AdvaMed supports widespread imple- mentation of the ratified WTO Trade Facilitation Agreement (TFA). A recent WTO study suggests that implementing TFA reforms could create more than 20 million jobs worldwide, particularly in Latin America’s emerging countries. AdvaMed welcomes working with partners to implement country-specific reforms, such as those recommended by the Organization for Economic Co-operation and Development (OECD)4 and the World Economic Forum Enabling Trade Report.5 ADVANCING TRADE FACILITATION 4 http://www2.compareyourcountry.org/trade-facilitation 5 http://reports.weforum.org/global-enabling-trade-report -2016/economy-profiles/